Form 4 Filing for CORCEPT THERAPEUTICS INC

Joseph Douglas Lyon, Chief Accounting & Technology Officer at CORCEPT THERAPEUTICS INC, reported several transactions on October 1st and 2nd, 2026. On October 1st, Lyon acquired 810 shares of Common Stock at $13.56 per share and disposed of 810 shares at a weighted average price of $115.3985. Additionally, a stock option for 810 shares with an exercise price of $13.56 was exercised. On October 2nd, Lyon acquired 3357 shares at $13.56 and 5833 shares at $19.26. Concurrently, 4446 shares were disposed of at a weighted average price of $115.6970, and 4744 shares at $115.6970. Two stock options were also exercised: one for 3357 shares with an exercise price of $13.56, and another for 5833 shares with an exercise price of $19.26. These transactions were made pursuant to a 10b5-1 plan. Footnote F1 details shares underlying unvested restricted stock awards.